Description
CDK4 regulation of breast cancer stem cells - A novel prognostic marker and therapeutic target for triple-negative breast cancer and chemotherapy-resistant tumors.
Amendment chain · 1 entry
Each notch is one published row for this agreement: #0 is the original (placed at its start date) and each later notch is an amendment (placed at its amendment date). The height is the agreement's total value as of that row — the source column is cumulative, not a change amount — so the line reads as the commitment over time and the right-most notch is the current commitment shown in the header.
- #02016-07-01$982,384
| Row | Date | Total value as of row | Change vs previous | Description on this row |
|---|---|---|---|---|
| #0 original | 2016-07-01(start date) | $982,384 | — | CDK4 regulation of breast cancer stem cells - A novel prognostic marker and therapeutic target for triple-nega… |
Related records · 6
Records are related by an explicit link in the data, stated for each group below — never by text similarity. Values are each agreement's current commitment (latest amendment).
Other current agreements for the same recipient (exact legal name match; no business number on file)
| Ref | Department · program | Current value | FY |
|---|---|---|---|
| 236-2025-2026-Q3-00001 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,193,400 | FY2026 |
| 236-2023-2024-Q1-00852 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,220,175 | FY2024 |
| 236-2022-2023-Q3-00330 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $1,046,520 | FY2023 |
| 236-2021-2022-Q4-00226 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Research in Priority Areas | $100,000 | FY2022 |
| 236-2019-2020-Q1-01455 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada · Investigator-Initiated Research | $956,250 | FY2020 |
| 236-2016-2017-Q2-00732 | Canadian Institutes of Health Research | Instituts de recherche en santé du Canada | $902,111 | FY2017 |
Cite as: Glassbox record view · Federal grants & contributions · 236-2016-2017-Q2-00166 · retrieved 2026-11-14.